Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Clinical trial NCT05044819 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05044819
Sponsor: Jazz Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Lennox Gastaut Syndrome Dravet Syndrome Tuberous Sclerosis Complex

Start date: 2021-07-07
Primary completion: 2027-08-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.